Sermorelin vs CJC-1295: the four residue substitutions that decide your half-life in published research
8 min read · Research use only
Written and reviewed by BluGen Research Team · Editorial standards
Same receptor, same 29-residue length, and a four-substitution structural difference that does almost all the work in published stability research. This is the comparison where "almost identical" actually means measurable.
Identity at a glance
Sermorelin is the native GHRH(1-29) sequence, MW ≈ 3,358 Da. CJC-1295 (no DAC) is GHRH(1-29) with four residue substitutions (positions 2, 8, 15 and 27) that resist DPP-IV proteolysis, MW ≈ 3,367 Da. The 9-Da mass difference hides a meaningful change in half-life behaviour in published assays.
Treat each SKU as a separate line on the CoA review even when they ship in the same procurement cycle. Sequence, modification and molecular weight are the fields that decide whether your protocol is reproducible.
Mechanism and research framing
Both engage the GHRH receptor on the somatotroph cell line literature. The downstream cAMP response is similar. What changes is the rate at which Sermorelin is cleaved by DPP-IV in serum-containing media, which makes time-course assays diverge cleanly even at matched starting concentrations.
Cite the literature each reference actually lives in, rather than transferring assumptions from the adjacent material. Matched buffers, matched controls and matched concentration ranges are the floor for comparative work.
Storage, stability and lab handling
Storage practices are nearly identical: cold, dry, lyophilised, light-protected. The real difference is in-solution stability — CJC-1295 retains structural integrity longer in reconstituted state, which matters for assays running over hours rather than minutes.
Aliquot before first freeze, label with lot and reconstitution date, and document freeze-thaw count per vial. Stability assumptions do not transfer between adjacent references even when the storage temperature does.
Next steps for procurement and the lab bench
If you are stocking Sermorelin and Cjc 1295 No Dac for parallel work, build the CoA package, the storage SOP and the reconstitution log before the order ships rather than after.
Pair this comparison with each product page, the matching product research guide, the storage guide and the CoA review guide. The internal links below route directly into those resources.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Frequently asked questions
Are Sermorelin and CJC-1295 (no DAC) the same peptide with different names?
No. Sermorelin is native GHRH(1-29). CJC-1295 (no DAC) is GHRH(1-29) with four specific substitutions. Sequence and stability differ.
For a time-course receptor-binding study, which is more appropriate?
CJC-1295 (no DAC) retains structural integrity longer in solution, which is why most extended-timepoint published assays use it over native GHRH(1-29).
Should I treat Sermorelin and Cjc 1295 No Dac as interchangeable in my study?
No. Even adjacent research references differ in receptor, sequence, modification, or stability. Review each CoA, storage SOP and protocol independently before substituting.
What is the highest-value field to compare first?
Sequence and receptor target. Molecular weight and HPLC purity validate the SKU, but receptor identity decides whether the materials are research-equivalent at all.
Citation
BluGen Research Peptides — Sermorelin vs CJC-1295: the four residue substitutions that decide your half-life in published research. https://getblugen.com/research/sermorelin-vs-cjc-1295-ghrh-research-comparison/. Accessed 2026-06-14.
Related catalog listings
Related research
Longevity
GHRP-6 vs Hexarelin: which secretagogue published binding studies actually pick, and why
Two hexapeptides, same receptor, almost the same molecular weight, and a measurable affinity gap that drives which one published binding studies actually pick. The choice is not arbitrary.
8 min read
Longevity
Thymosin Alpha-1: Research overview, identity, and laboratory handling guide
Acetylated 28-residue thymic peptide studied in vitro for immune-cell signaling and cytokine-pathway research. ≥99% HPLC. Research use only. This guide covers identity, published research context, procurement checks, and storage — RUO only, no clinical claims.
8 min read
Longevity
Sermorelin: Research overview, identity, and laboratory handling guide
Synthetic 29-residue GHRH(1-29) analogue widely studied in vitro for GHRH-receptor binding research. ≥99% HPLC. Research use only. This guide covers identity, published research context, procurement checks, and storage — RUO only, no clinical claims.
8 min read